Thromb Haemost 2016; 116(05): 967-974
DOI: 10.1160/TH16-03-0205
Stroke, Systemic or Venous Thromboembolism
Schattauer GmbH

Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France

Aurélien Delluc
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Cécile Tromeur
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Florent Le Ven
3   Department of Cardiology, Brest University Hospital, Brest, France
,
Maelenn Gouillou
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Nicolas Paleiron
5   Respirology unit, Brest Military Hospital “Clermont-Tonnerre”, BCRM Brest, CC41, Brest, France
,
Luc Bressollette
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Michel Nonent
6   Department of Radiology, Brest University Hospital, Brest, France
,
Pierre-Yves Salaun
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
7   Department of Nuclear Medicine, Brest University Hospital, Brest, France
,
Karine Lacut
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Christophe Leroyer
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Grégoire Le Gal
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Francis Couturaud
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Dominique Mottier
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
for the EPIGETBO study group› Author Affiliations
Further Information

Publication History

Received: 11 March 2016

Accepted after major revision: 04 July 2016

Publication Date:
11 November 2017 (online)

Preview

Summary

In 1998 we estimated the incidence of venous thromboembolism (VTE) to be 1.8/1,000 per year. The aim of this study was to compare current VTE incidence to that observed in 1998. We prospectively recorded all cases of symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) of the lower limbs diagnosed between March 1, 2013 and February 28, 2014 in hospitals and in the community, using the same method and geographic area than in 1998. The 2013 incidence rates of VTE were computed and compared with those of 1998 using age- and sex-specific standardised incidence ratios (SIRs). In 2013, we recorded 576 VTE cases (279 isolated DVT and 297 PE ± DVT). Among 367,911 inhabitants, the overall incidence of VTE was 1.57/1,000 (95 % CI 1.44–1.69). The overall VTE incidence was significantly lower in 2013 as compared with 1998: SIR 0.72 (95 % CI 0.67–0.79) as well as the incidence of isolated DVT: SIR 0.53 (95 % CI 0.47–0.60); conversely, the overall incidence of PE was unchanged: SIR 1.10 (95 % CI, 0.98–1.23) despite an increase in the incidence of isolated PE: SIR 1.29 (95 % CI, 1.10–1.52). In 1998, 4.4 % of PE cases were diagnosed using CTPA as compared with 73.7 % in 2013 (p < 0.001). In conclusion, between 1998 and 2013, the incidence of symptomatic DVT decreased. Conversely, we found no similar reduction in the incidence of symptomatic PE; whether this is due to changes in diagnostic tests and algorithms in the management of suspected PE requires further investigations.

Supplementary Material to this paper is available online at www.thrombosis-online.com.